Diabetes
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Perioperative Insulin Pump Guidelines (Protocol)
SGLT-2 Receptor Inhibitors: Pharmacology and Anaesthetic Implications
Update on the perioperative management of diabetes mellitus
Open Anesthesia: Perioperative Management of Patients with Type 1 Diabetes Mellitus
Open Anesthesia: Glucose Homeostasis and Insulin Therapy
Perioperative Management of Patients with Type 1 Diabetes Mellitus
Kapellen T, Agwu JC, Martin L, et al. ISPAD clinical practice consensus guidelines 2022: Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes 2022; 23(8): 1468-77.
Vanderhoek SM, Moini A, Prichett L, Wolf RM. Practice patterns of perioperative insulin pump management in pediatric diabetes. Paediatric anaesthesia 2021; 31(7): 827-9.
New Antiobesity Medications, GLP-1, and GIP Receptor Agonists and their Anaesthetic Implications
Perioperative Management of Diabetic Patients: Optimising Care with Insulin Pumps and CGM Devices
Perioperative Care of Patients Using Wearable Diabetes Devices
Error traps in the perioperative management of children with type 1 diabetes
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study
Arcuri L. GLP-1 Drugs and the physiology of metabolic health. The Physiologist Magazine. American Physiological Society; 2026.
Moiz A, Filion KB, Toutounchi H, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ. Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials. Ann Intern Med. 2025;178(2):199–217. doi:10.7326/ANNALS-24-01590.
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes. N Engl J Med. 2025;392(20):2001–2012.